Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer.

Haura EB, Ricart AD, Larson TG, Stella PJ, Bazhenova L, Miller VA, Cohen RB, Eisenberg PD, Selaru P, Wilner KD, Gadgeel SM.

Clin Cancer Res. 2010 Apr 15;16(8):2450-7. doi: 10.1158/1078-0432.CCR-09-1920. Epub 2010 Mar 23.

2.

Cloning and characterization of a general amino acid control transcriptional activator from the chestnut blight fungus Cryphonectria parasitica.

Wang P, Larson TG, Chen CH, Pawlyk DM, Clark JA, Nuss DL.

Fungal Genet Biol. 1998 Feb;23(1):81-94.

PMID:
9501479
4.

Cyclophilin-dependent stimulation of transcription by cyclosporin A.

Larson TG, Nuss DL.

Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):148-52.

5.
6.
7.
10.

Limbitrol--a medical dream or nightmare.

Larson TG.

Minn Med. 1979 Oct;62(10):725-6. No abstract available.

PMID:
502988
11.

Alcoholism and drugs. Addiction.

Larson TG.

Minn Med. 1972 Dec;55(12):1144-6. No abstract available.

PMID:
4669992
12.

Addiction. Cases treated on a psychiatric service.

Koutsky CD, Larson TG.

Minn Med. 1967 Feb;50(2):189-94. No abstract available.

PMID:
4382416

Supplemental Content

Loading ...
Support Center